MétaCan
Menu
Back to cohort
Record W3175982156 · doi:10.1016/j.jaip.2021.06.006

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

2021· review· en· W3175982156 on OpenAlexafffund
Matthew Greenhawt, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David A. Khan, Cem Akin, Waleed Alqurashi, Peter D. Arkwright, James L. Baldwin, Moshe Ben‐Shoshan, Jonathan A. Bernstein, Theresa Bingemann, Katharina Blümchen, Aideen Byrne, Antonio Bognanni, Dianne E. Campbell, Ronna L. Campbell, Zain Chagla, Edmond S. Chan, Jeffrey Shi Kai Chan, Pasquale Comberiati, Timothy E. Dribin, Anne K. Ellis, David M. Fleischer, Adam Fox, Pamela A. Frischmeyer‐Guerrerio, Rémi Gagnon, Mitchell H. Grayson, Caroline C. Horner, Jonathan O’B Hourihane, Constance H. Katelaris, Harold Kim, John M. Kelso, David M. Lang, Dennis K. Ledford, Michael Levin, Phil Lieberman, Richard Loh, Doug Mack, Bruce Mazer, Giselle Mosnaim, Daniel Munblit, S. Shahzad Mustafa, Anil Nanda, John Oppenheimer, Kirsten P. Perrett, Allison Ramsey, Matthew A. Rank, Kara Robertson, Javed Sheikh, Jonathan M. Spergel, David R. Stukus, Mimi L.K. Tang, James M. Tracy, Paul Turner, Anna Whalen-Browne, Dana Wallace, Julie Wang, Susan Waserman, John K. Witry, Margitta Worm, Timothy K. Vander Leek, David B.K. Golden

Bibliographic record

VenueThe Journal of Allergy and Clinical Immunology In Practice · 2021
Typereview
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsUniversity of AlbertaSt Joseph's Health CareBC Children's HospitalMcGill UniversityUniversity of OttawaQueen's UniversityMcMaster UniversityUniversity of British ColumbiaUniversity of ManitobaSt. Joseph’s Healthcare HamiltonImpactSouthlake Regional Health CenterWestern UniversityMontreal Children's Hospital
FundersNHLBI Division of Intramural ResearchNational Institute of Allergy and Infectious DiseasesGenentechAllergy TherapeuticsNational Institutes of HealthNational Peanut BoardPfizerInstitute for Health Metrics and EvaluationRegeneron PharmaceuticalsDivision of Intramural Research, National Institute of Allergy and Infectious DiseasesSanofiAstraZenecaBausch HealthAmerican Academy of Allergy Asthma and Immunology
KeywordsMedicineMeta-analysisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMEDLINERisk assessmentIntensive care medicineFamily medicineVirologyInternal medicine

Abstract

fetched live from OpenAlex

Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international experts in anaphylaxis composed of allergy, infectious disease, emergency medicine, and front-line clinicians to systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions. Medline, EMBASE, Web of Science, the World Health Organizstion (WHO) global coronavirus database, and the gray literature (inception, March 19, 2021) were systematically searched. Paired reviewers independently selected studies addressing anaphylaxis after SARS-CoV-2 vaccination, polyethylene glycol (PEG) and polysorbate allergy, and accuracy of allergy testing for SARS-CoV-2 vaccine allergy. Random effects models synthesized the data to inform recommendations based on the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach, agreed upon using a modified Delphi panel. The incidence of SARS-CoV-2 vaccine anaphylaxis is 7.91 cases per million (n = 41,000,000 vaccinations; 95% confidence interval [95% CI] 4.02-15.59; 26 studies, moderate certainty), the incidence of 0.15 cases per million patient-years (95% CI 0.11-0.2), and the sensitivity for PEG skin testing is poor, although specificity is high (15 studies, very low certainty). We recommend vaccination over either no vaccination or performing SARS-CoV-2 vaccine/excipient screening allergy testing for individuals without history of a severe allergic reaction to the SARS-CoV-2 vaccine/excipient, and a shared decision-making paradigm in consultation with an allergy specialist for individuals with a history of a severe allergic reaction to the SARS-CoV-2 vaccine/excipient. We recommend further research to clarify SARS-CoV-2 vaccine/vaccine excipient testing utility in individuals potentially allergic to SARS-CoV2 vaccines or their excipients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.076
metaresearch head score (Gemma)0.177
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.076
Threshold uncertainty score0.400

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0760.177
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0210.035
Bibliometrics0.0170.010
Science and technology studies0.0010.002
Scholarly communication0.0060.004
Open science0.0050.003
Research integrity0.0040.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.273
GPT teacher head0.537
Teacher spread0.264 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations210
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of Allergy and Clinical Immunology In PracticeSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207